# STEMLINE THERAPEUTICS INC — Form D

STEMLINE THERAPEUTICS INC of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2010-03-29. The offering totals $1.3M, of which $1.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2010-03-29
- Form: D
- Accession: 0001264587-10-000003
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $1.3M
- Amount sold: $1.3M
- Investors: 5
- Date of first sale: 2010-03-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-58823

## Issuer

- Name: STEMLINE THERAPEUTICS INC
- CIK: 0001264587
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 1675 YORK AVENUE, SUITE 34-L, NEW YORK, NY, 10128
- Phone: 212-531-5969

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Ivan Bergstein | Director | New York, NY |
| Ivan Bergstein | Executive Officer | New York, NY |
| Ronald Bentsur | Director | New York, NY |
| Ivan Bergstein, M.D. | Director | New York, NY |
| Ivan Bergstein, M.D. | Executive Officer | New York, NY |

## Other filings by this issuer (2)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2012-01-17](https://search.stillhousedata.com/formd/0000908662-12-000005) | D | — | $740K |
| [2010-04-27](https://search.stillhousedata.com/formd/0001264587-10-000004) | D | $600K | $600K |

## More

- [CIK 1264587 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1264587&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001264587-10-000003.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.